Thanks @patyccc that makes sense.
@aruc6393 Agree, it is dragging on but COVID wasn't exactly in their roadmap. Fact is there is not much that can be done until pathology labs can get a break from COVID testing. I would strongly urge anyone to sell now if they aren't prepared to wait this out.
Yes cash burn was high but for good reason, as mentioned in the quarterly:
That's allot of consultancy work (usually billed in hours).
As a FYI to anyone interested, the Payer Budget study was done by our friends over at Renalytix about a year ago.
https://renalytixai.com/wp-content/uploads/2020/03/BHA-Renalytix-KidneyIntelX-NKF-Poster-3.25.20-FINAL-002.pdf
They received their CPT code 3 months after publication.
I am confident Richard and the team will secure the reimbursement code this calendar year. This will be very significant milestone and significantly de-risk our investment here.
- Forums
- ASX - By Stock
- Ann: December 2020 Quarterly Activities Report and Appendix 4C
Thanks @patyccc that makes sense.@aruc6393 Agree, it is dragging...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PIQ (ASX) to my watchlist
|
|||||
Last
97.0¢ |
Change
0.015(1.57%) |
Mkt cap ! $127.0M |
Open | High | Low | Value | Volume |
99.5¢ | 99.5¢ | 96.3¢ | $64.34K | 65.56K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 15200 | 96.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
98.0¢ | 22247 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 15200 | 0.960 |
1 | 13628 | 0.955 |
4 | 21000 | 0.950 |
1 | 10560 | 0.945 |
1 | 16000 | 0.935 |
Price($) | Vol. | No. |
---|---|---|
0.980 | 22247 | 2 |
0.990 | 6220 | 1 |
1.000 | 2875 | 1 |
1.010 | 13000 | 1 |
1.020 | 4750 | 1 |
Last trade - 15.58pm 16/07/2024 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |